Total Payments
$12,703
2024 Payments
$1,498
Companies
47
Transactions
425
Medicare Patients
2,849
Medicare Billing
$1.5M
Payment Breakdown by Category
Food & Beverage$12,492 (98.3%)
Education$210.65 (1.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,492 | 416 | 98.3% |
| Education | $210.65 | 9 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,074 | 64 | $0 (2024) |
| Fresenius USA Marketing, Inc. | $2,013 | 76 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $726.10 | 27 | $0 (2024) |
| Novo Nordisk Inc | $626.03 | 29 | $0 (2024) |
| Abbott Laboratories | $589.11 | 6 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $553.37 | 10 | $0 (2022) |
| Amgen Inc. | $522.85 | 12 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $510.74 | 22 | $0 (2021) |
| Relypsa, Inc. | $484.94 | 15 | $0 (2019) |
| Lilly USA, LLC | $463.32 | 17 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,498 | 44 | Fresenius USA Marketing, Inc. ($420.59) |
| 2023 | $1,096 | 31 | Fresenius USA Marketing, Inc. ($339.38) |
| 2022 | $1,480 | 53 | Fresenius USA Marketing, Inc. ($346.19) |
| 2021 | $1,727 | 75 | AstraZeneca Pharmaceuticals LP ($367.41) |
| 2020 | $994.40 | 43 | AstraZeneca Pharmaceuticals LP ($389.07) |
| 2019 | $1,001 | 38 | AstraZeneca Pharmaceuticals LP ($228.84) |
| 2018 | $1,326 | 42 | Fresenius USA Marketing, Inc. ($284.91) |
| 2017 | $3,580 | 99 | SANOFI-AVENTIS U.S. LLC ($516.18) |
All Payment Transactions
425 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: Phosphate binder for ESRD | ||||||
| 11/11/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $25.06 | General |
| Category: Phosphate binder for ESRD | ||||||
| 10/29/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $124.45 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: Phosphate binder for ESRD | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $129.68 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $32.65 | General |
| Category: Diabetes | ||||||
| 10/07/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: Immunology | ||||||
| 10/07/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: Immunology | ||||||
| 09/10/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: Hyperkalemia | ||||||
| 09/05/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Education | In-kind items and services | $24.61 | General |
| Category: Nephrology | ||||||
| 08/26/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: IMMUNOLOGY | ||||||
| 08/21/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: Phosphate binder for ESRD | ||||||
| 08/15/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $32.62 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/15/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $1.90 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/26/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.62 | General |
| Category: Diabetes | ||||||
| 06/26/2024 | Novo Nordisk Inc | Saxenda (Drug), Wegovy | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: Obesity | ||||||
| 06/24/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: IMMUNOLOGY | ||||||
| 06/21/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: Diabetes | ||||||
| 06/13/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: Diabetes | ||||||
| 06/06/2024 | Vifor Pharma, Inc. | — | Food and Beverage | In-kind items and services | $18.08 | General |
| 05/30/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 05/23/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $131.20 | General |
| Category: Phosphate binder for ESRD | ||||||
| 05/23/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $7.89 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 591 | 1,598 | $531,700 | $304,955 |
| 2022 | 8 | 619 | 1,820 | $599,450 | $345,684 |
| 2021 | 9 | 677 | 2,088 | $686,550 | $421,883 |
| 2020 | 10 | 962 | 2,436 | $793,050 | $395,418 |
Total Patients
2,849
Total Services
7,942
Medicare Billing
$1.5M
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 143 | 533 | $213,200 | $140,015 | 65.7% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 85 | 285 | $142,500 | $89,512 | 62.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 174 | 469 | $93,800 | $32,185 | 34.3% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2023 | 87 | 177 | $53,100 | $32,003 | 60.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 29 | 29 | $8,700 | $3,716 | 42.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 28 | 48 | $9,600 | $3,243 | 33.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 16 | 18 | $4,950 | $1,852 | 37.4% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 17 | 26 | $3,900 | $1,609 | 41.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 13 | $1,950 | $820.71 | 42.1% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 160 | 595 | $238,000 | $157,133 | 66.0% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 75 | 315 | $157,500 | $100,559 | 63.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 180 | 550 | $110,000 | $38,122 | 34.7% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2022 | 100 | 203 | $60,900 | $37,092 | 60.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 38 | 79 | $15,800 | $4,946 | 31.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 29 | 29 | $8,700 | $4,127 | 47.4% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 25 | 37 | $5,550 | $2,383 | 42.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 12 | 12 | $3,000 | $1,322 | 44.1% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2021 | 167 | 701 | $280,400 | $187,589 | 66.9% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 89 | 339 | $169,500 | $109,754 | 64.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 192 | 589 | $117,800 | $62,886 | 53.4% |
| 90962 | Dialysis services (1 physician visit per month), patient 20 years of age and older | Office | 2021 | 119 | 227 | $68,100 | $41,658 | 61.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 33 | 126 | $25,200 | $8,087 | 32.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 16 | 20 | $7,500 | $3,578 | 47.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 25 | 25 | $7,500 | $3,571 | 47.6% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2021 | 22 | 47 | $7,050 | $3,059 | 43.4% |
About Dr. Elwin Bustos, MD
Dr. Elwin Bustos, MD is a Preferred Provider Organization healthcare provider based in Washington, District of Columbia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1467543686.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Elwin Bustos, MD has received a total of $12,703 in payments from pharmaceutical and medical device companies, with $1,498 received in 2024. These payments were reported across 425 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($12,492).
As a Medicare-enrolled provider, Bustos has provided services to 2,849 Medicare beneficiaries, totaling 7,942 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Preferred Provider Organization
- Other Specialties Health Maintenance Organization, Primary Care
- Location Washington, DC
- Active Since 09/27/2006
- Last Updated 10/03/2025
- Taxonomy Code 305R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1467543686
Products in Payments
- Velphoro (Drug) $2,013
- ACTHAR (Biological) $1,055
- FARXIGA (Drug) $946.25
- CardioMEMS HF System (Device) $589.11
- Veltassa (Drug) $502.45
- LOKELMA (Drug) $405.16
- TOUJEO (Drug) $381.36
- TRULICITY (Drug) $351.47
- JANUVIA (Drug) $315.34
- JARDIANCE (Drug) $286.97
- ENTRESTO (Drug) $274.74
- JYNARQUE (Drug) $249.64
- Ozempic (Drug) $230.47
- Parsabiv (Drug) $227.18
- BREZTRI (Drug) $219.33
- KRYSTEXXA (Biological) $187.22
- Victoza (Drug) $184.87
- Auryxia (Drug) $178.61
- BEVESPI AEROSPHERE (Drug) $172.35
- XARELTO (Drug) $150.65
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.